Atractylenolide III (ICodonolactone) may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of Bax and translocating apoptosis-inducing factor.
Molecular Weight:
248.32
Purity:
99.53%
CAS Number:
[73030-71-4]
Formula:
C15H20O3
Target:
Apoptosis
T3902
* VAT and and shipping costs not included. Errors and price changes excepted